These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33116586)

  • 1.
    Lv Z; Cong R; Li J; Cao K; Bao Q; Li L; Yang F; Yuan J
    Onco Targets Ther; 2020; 13():10013-10023. PubMed ID: 33116586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EZH2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia.
    Cao W; Younis RH; Li J; Chen H; Xia R; Mao L; Chen W; Ren H
    Cancer Prev Res (Phila); 2011 Nov; 4(11):1816-24. PubMed ID: 21697275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of SMAD4 expression and histological grade of dysplasia is a better predictor for the malignant transformation of oral leukoplakia.
    Xia RH; Song XM; Wang XJ; Li J; Mao L
    PLoS One; 2013; 8(6):e66794. PubMed ID: 23826135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
    Liu W; Yao Y; Shi L; Tang G; Wu L
    J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
    Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
    J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics in oral leukoplakia and oral squamous cell carcinoma.
    Sridharan G; Ramani P; Patankar S
    J Cancer Res Ther; 2017; 13(3):556-561. PubMed ID: 28862226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human MutL homolog 1 immunoexpression in oral leukoplakia and oral squamous cell carcinoma: A prospective study in Indian population.
    Chaudhari NT; Tupkari JV; Joy T; Ahire MS
    J Oral Maxillofac Pathol; 2016; 20(3):453-461. PubMed ID: 27721611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parathyroid Hormone-Like Hormone is a Poor Prognosis Marker of Head and Neck Cancer and Promotes Cell Growth via RUNX2 Regulation.
    Chang WM; Lin YF; Su CY; Peng HY; Chang YC; Hsiao JR; Chen CL; Chang JY; Shieh YS; Hsiao M; Shiah SG
    Sci Rep; 2017 Jan; 7():41131. PubMed ID: 28120940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis reveals the protein profile associated with malignant transformation of oral leukoplakia.
    Normando AGC; Dos Santos ES; Sá JO; Busso-Lopes AF; De Rossi T; Patroni FMS; Granato DC; Guerra ENS; Santos-Silva AR; Lopes MA; Paes Leme AF
    Front Oral Health; 2023; 4():1088022. PubMed ID: 36923449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    G D; Nandan SRK; Kulkarni PG
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum lipids and lipoproteins as prognosticators in leukoplakia.
    Ganavi BS; Patil S; Rao RS
    J Contemp Dent Pract; 2014 May; 15(3):294-9. PubMed ID: 25307809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early findings of a novel established molecular diagnostic technique for the prediction of malignant transformation in leukoplakia.
    Ries J; Ponader S; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
    Mol Med Rep; 2009; 2(6):947-52. PubMed ID: 21475926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin induces parathyroid hormone-like hormone expression in gastric parietal cells.
    Al Menhali A; Keeley TM; Demitrack ES; Samuelson LC
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G649-G657. PubMed ID: 28408643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant transformation rate of oral leukoplakia in an Australian population.
    Shearston K; Fateh B; Tai S; Hove D; Farah CS
    J Oral Pathol Med; 2019 Aug; 48(7):530-537. PubMed ID: 31172563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
    von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
    BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.